Missense polymorphisms in three oxidative-stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia

A. F Y Al Hadithy, S. A. Ivanova, P. Pechlivanoglou, B. Wilffert, A. Semke, O. Fedorenko, E. Kornetova, L. Ryadovaya, J. R B J Brouwers, A. J M Loonen

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Neuronal degeneration due to oxidative stress (OS) has been proposed as a mechanism for tardive dyskinesia (TD) pathogenesis. Cellular defense mechanisms against OS may involve detoxification enzymes (e.g., glutathione peroxidase-1, GPX1; superoxide dismutase-2, SOD2 [also commonly known as MnSOD]; and glutathione S-transferase P1, GSTP1). Several pharmacogenetic studies have examined TD and OS in different ethnic groups, but not in Russians. Here we report the association between orofaciolingual (TDof) and limb-truncal dyskinesias (TDlt) and polymorphisms of GSTP1 (Ile105Val), MnSOD (Ala-9Val), and GPX1 (Pro197Leu) genes in 146 Russian inpatients from Siberia. We applied AIMS instrument to rate dyskinesias. Two-part model analyses, logistic and multivariate parametric regressions were applied to assess the effects of different variables (e.g., genotype, age, gender, and medication use). Our analyses do not suggest that Pro197Leu (GPX1) is associated with TD. However, our analyses suggest that the 105Val-allele of Ile105Val (GSTP1) may be associated with a lower risk and a severity of TDof and TDlt and that Ile105Val pharmacogenetics may be different in Slavonic Caucasians from that in American Caucasians. Furthermore, we find evidence for an association between Ala-9Val (MnSOD) and TDof, but not TDlt. Subject to further replication, our findings extend the available knowledge on the pharmacogenetics of TD and oxidative stress.

Original languageEnglish
Pages (from-to)84-91
Number of pages8
JournalHuman Psychopharmacology
Volume25
Issue number1
DOIs
Publication statusPublished - 2010

Fingerprint

Siberia
Dyskinesias
Psychiatry
Inpatients
Oxidative Stress
Extremities
Pharmacogenetics
Enzymes
Glutathione Transferase
Ethnic Groups
Multivariate Analysis
Logistic Models
Alleles
Genotype
Tardive Dyskinesia
Genes
glutathione peroxidase GPX1

Keywords

  • GPX1
  • GSTP1
  • MnSOD
  • Oxidative stress
  • Pharmacogenetics
  • SOD2
  • Tardive dyskinesia

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Neurology
  • Pharmacology (medical)

Cite this

Missense polymorphisms in three oxidative-stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia. / Al Hadithy, A. F Y; Ivanova, S. A.; Pechlivanoglou, P.; Wilffert, B.; Semke, A.; Fedorenko, O.; Kornetova, E.; Ryadovaya, L.; Brouwers, J. R B J; Loonen, A. J M.

In: Human Psychopharmacology, Vol. 25, No. 1, 2010, p. 84-91.

Research output: Contribution to journalArticle

Al Hadithy, AFY, Ivanova, SA, Pechlivanoglou, P, Wilffert, B, Semke, A, Fedorenko, O, Kornetova, E, Ryadovaya, L, Brouwers, JRBJ & Loonen, AJM 2010, 'Missense polymorphisms in three oxidative-stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia', Human Psychopharmacology, vol. 25, no. 1, pp. 84-91. https://doi.org/10.1002/hup.1087
Al Hadithy, A. F Y ; Ivanova, S. A. ; Pechlivanoglou, P. ; Wilffert, B. ; Semke, A. ; Fedorenko, O. ; Kornetova, E. ; Ryadovaya, L. ; Brouwers, J. R B J ; Loonen, A. J M. / Missense polymorphisms in three oxidative-stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia. In: Human Psychopharmacology. 2010 ; Vol. 25, No. 1. pp. 84-91.
@article{2f2bc8e33cce43d194ba83fd0009ec61,
title = "Missense polymorphisms in three oxidative-stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia",
abstract = "Neuronal degeneration due to oxidative stress (OS) has been proposed as a mechanism for tardive dyskinesia (TD) pathogenesis. Cellular defense mechanisms against OS may involve detoxification enzymes (e.g., glutathione peroxidase-1, GPX1; superoxide dismutase-2, SOD2 [also commonly known as MnSOD]; and glutathione S-transferase P1, GSTP1). Several pharmacogenetic studies have examined TD and OS in different ethnic groups, but not in Russians. Here we report the association between orofaciolingual (TDof) and limb-truncal dyskinesias (TDlt) and polymorphisms of GSTP1 (Ile105Val), MnSOD (Ala-9Val), and GPX1 (Pro197Leu) genes in 146 Russian inpatients from Siberia. We applied AIMS instrument to rate dyskinesias. Two-part model analyses, logistic and multivariate parametric regressions were applied to assess the effects of different variables (e.g., genotype, age, gender, and medication use). Our analyses do not suggest that Pro197Leu (GPX1) is associated with TD. However, our analyses suggest that the 105Val-allele of Ile105Val (GSTP1) may be associated with a lower risk and a severity of TDof and TDlt and that Ile105Val pharmacogenetics may be different in Slavonic Caucasians from that in American Caucasians. Furthermore, we find evidence for an association between Ala-9Val (MnSOD) and TDof, but not TDlt. Subject to further replication, our findings extend the available knowledge on the pharmacogenetics of TD and oxidative stress.",
keywords = "GPX1, GSTP1, MnSOD, Oxidative stress, Pharmacogenetics, SOD2, Tardive dyskinesia",
author = "{Al Hadithy}, {A. F Y} and Ivanova, {S. A.} and P. Pechlivanoglou and B. Wilffert and A. Semke and O. Fedorenko and E. Kornetova and L. Ryadovaya and Brouwers, {J. R B J} and Loonen, {A. J M}",
year = "2010",
doi = "10.1002/hup.1087",
language = "English",
volume = "25",
pages = "84--91",
journal = "Human Psychopharmacology",
issn = "0885-6222",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Missense polymorphisms in three oxidative-stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia

AU - Al Hadithy, A. F Y

AU - Ivanova, S. A.

AU - Pechlivanoglou, P.

AU - Wilffert, B.

AU - Semke, A.

AU - Fedorenko, O.

AU - Kornetova, E.

AU - Ryadovaya, L.

AU - Brouwers, J. R B J

AU - Loonen, A. J M

PY - 2010

Y1 - 2010

N2 - Neuronal degeneration due to oxidative stress (OS) has been proposed as a mechanism for tardive dyskinesia (TD) pathogenesis. Cellular defense mechanisms against OS may involve detoxification enzymes (e.g., glutathione peroxidase-1, GPX1; superoxide dismutase-2, SOD2 [also commonly known as MnSOD]; and glutathione S-transferase P1, GSTP1). Several pharmacogenetic studies have examined TD and OS in different ethnic groups, but not in Russians. Here we report the association between orofaciolingual (TDof) and limb-truncal dyskinesias (TDlt) and polymorphisms of GSTP1 (Ile105Val), MnSOD (Ala-9Val), and GPX1 (Pro197Leu) genes in 146 Russian inpatients from Siberia. We applied AIMS instrument to rate dyskinesias. Two-part model analyses, logistic and multivariate parametric regressions were applied to assess the effects of different variables (e.g., genotype, age, gender, and medication use). Our analyses do not suggest that Pro197Leu (GPX1) is associated with TD. However, our analyses suggest that the 105Val-allele of Ile105Val (GSTP1) may be associated with a lower risk and a severity of TDof and TDlt and that Ile105Val pharmacogenetics may be different in Slavonic Caucasians from that in American Caucasians. Furthermore, we find evidence for an association between Ala-9Val (MnSOD) and TDof, but not TDlt. Subject to further replication, our findings extend the available knowledge on the pharmacogenetics of TD and oxidative stress.

AB - Neuronal degeneration due to oxidative stress (OS) has been proposed as a mechanism for tardive dyskinesia (TD) pathogenesis. Cellular defense mechanisms against OS may involve detoxification enzymes (e.g., glutathione peroxidase-1, GPX1; superoxide dismutase-2, SOD2 [also commonly known as MnSOD]; and glutathione S-transferase P1, GSTP1). Several pharmacogenetic studies have examined TD and OS in different ethnic groups, but not in Russians. Here we report the association between orofaciolingual (TDof) and limb-truncal dyskinesias (TDlt) and polymorphisms of GSTP1 (Ile105Val), MnSOD (Ala-9Val), and GPX1 (Pro197Leu) genes in 146 Russian inpatients from Siberia. We applied AIMS instrument to rate dyskinesias. Two-part model analyses, logistic and multivariate parametric regressions were applied to assess the effects of different variables (e.g., genotype, age, gender, and medication use). Our analyses do not suggest that Pro197Leu (GPX1) is associated with TD. However, our analyses suggest that the 105Val-allele of Ile105Val (GSTP1) may be associated with a lower risk and a severity of TDof and TDlt and that Ile105Val pharmacogenetics may be different in Slavonic Caucasians from that in American Caucasians. Furthermore, we find evidence for an association between Ala-9Val (MnSOD) and TDof, but not TDlt. Subject to further replication, our findings extend the available knowledge on the pharmacogenetics of TD and oxidative stress.

KW - GPX1

KW - GSTP1

KW - MnSOD

KW - Oxidative stress

KW - Pharmacogenetics

KW - SOD2

KW - Tardive dyskinesia

UR - http://www.scopus.com/inward/record.url?scp=76149127358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76149127358&partnerID=8YFLogxK

U2 - 10.1002/hup.1087

DO - 10.1002/hup.1087

M3 - Article

C2 - 20041472

AN - SCOPUS:76149127358

VL - 25

SP - 84

EP - 91

JO - Human Psychopharmacology

JF - Human Psychopharmacology

SN - 0885-6222

IS - 1

ER -